Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,542,132
+$26,594,394 QoQ
Shares Held
6,925,067
+196.3% QoQ
Ownership
3.39%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#6
of 216 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ANNX ranks #36 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in ANNX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,542,132 | 6,925,067 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,947,738 | 2,337,137 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,080,371 | 4,000,074 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,046,738 | 2,638,275 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,528,901 | 1,053,709 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,081,363 | 2,114,696 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,803,737 | 2,690,787 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,306,547 | 3,430,160 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,951,217 | 4,071,677 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,344,366 | 2,000,609 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,080,000 | 2,000,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,455,901 | 1,464,365 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,480,272 | 704,623 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,111,624 | 548,474 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $908,110 | 175,650 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,797,738 | 1,261,770 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,544,305 | 409,630 | Shares | Sole | 2022-08-15 | |
| 2020-09-30 | $6,068,309 | 200,738 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||